Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas

Cheng Wei(Tianjin Medical University General Hospital), Jianning Zhang(The University of Texas Southwestern Medical Center), Ze‐Sheng Li(Tianjin Medical University General Hospital), Yingjie He(Hubei University), Xiaoyang Zhang(University of Utah), Lei Han(Affiliated Hospital of Jining Medical University), Zhenyu Zhang(Dalian Medical University), Bo Wang(Peking University), Shenghui Li(Taixing People's Hospital), Lin Luo(Shanghai Jiao Tong University), Hao Liang(ShanghaiTech University), Dazhao Peng(Tianjin Medical University General Hospital), Shu Zhang(BGI Group (China)), Xuezhi Du(Second Hospital of Tianjin Medical University)
Frontiers in Immunology
June 23, 2022
Cited by 2


Related Papers